Immuno-TLC of A: anti-FMC-7 antibody with LPS from E. coli J5 strain (lane 1), glycoglycerolipid MfGL-II from Mycoplasma fermentans (lane 2), and FMC-7 (lane 3); B: MS CSF IgG with: LPS from E. coli J5 strain (lane 1), glycoglycerolipid MfGL-II from Mycoplasma fermentans (lane 2), and FMC-7 (lane 3); C: anti-FMC-5/-6/-7 antibody with: EBs Chlamydia pneumoniae (lane 1), MfGL-II (lane 2), mixture FMC-5/-6/-7 (lane 3), and GalCer (lane 4); D: MS CSF IgG with FMC-5/-6/-7 mixture (lane 1), FMC-1 (lane 2), EBs Chlamydia pneumoniae (lane 3), and MfGL-II (lane 4). The bands were resolved on the plate using for 6A and 6B→ n-propanol:methanol:water (50:30:20; v/v/v) and for 6C and 6D→ n-propanol:methanol:water (60:20:15; v/v/v), respectively, and then visualized with DAB staining. Abbreviations: CSF, cerebrospinal fluid; FMC, fast migrating cerebroside; GalCer, galactosylceramide; LPS, lipopolisaccharide; MS, multiple sclerosis.